Can a smartphone app help teen cancer survivors conquer chronic pain?

NCT ID NCT07160621

Recruiting now Symptom relief Sponsor: St. Jude Children's Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a mobile app that teaches cognitive behavioral therapy (CBT) can reduce chronic pain and improve daily functioning in adolescent survivors of childhood cancer. Researchers will compare the app to standard pain education in 228 participants (teens and their caregivers) across four U.S. hospitals. The goal is to find a more accessible, culturally sensitive way to help these teens manage pain and get back to normal activities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cognitive Behavioral Therapy (CBT) delivered via a mobile app
What this could lead to: If it works, this could provide a convenient, culturally adapted way to help teen cancer survivors manage chronic pain and improve their daily lives.
What could go wrong: This is a relatively small, early-stage behavioral trial. The app may not work better than standard education, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD CANCER SURVIVOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDHOOD CANCER SURVIVOR CHRONIC PAIN

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

St. Jude Children's Research Hospital
RECRUITING

Memphis, Tennessee, 38105, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.